Céline Montavon Selected Research

Céline Montavon Research Topics

6	Neoplasms (Cancer) 03/2024 - 03/2012
3	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 03/2012
2	Hypersensitivity (Allergy) 03/2024 - 12/2023
2	Filarial Elephantiasis (Lymphatic Filariasis) 01/2017 - 12/2016
1	Anaphylaxis (Anaphylactic Shock) 12/2023
1	Myoma 01/2023
1	Osteoporosis 06/2022
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Lymphatic Metastasis 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2019
1	Vulvitis 10/2019
1	Onchocerciasis 01/2017
1	Loiasis 01/2017
1	Carcinoma (Carcinomatosis) 03/2012
1	hereditary Thrombophilia 10/2008
1	Fetal Diseases (Embryopathy) 10/2008
1	Hemorrhage 10/2008

2	taxaneIBA 03/2024 - 12/2023
2	PlatinumIBA 03/2024 - 12/2023
2	Hormones (Hormone)IBA 11/2022 - 06/2022
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 03/2012
1	SaltsIBA 03/2024
1	Carboplatin (JM8)FDA LinkGeneric 12/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2023
1	Estrogens (Estrogen)FDA Link 11/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2022
1	Diphosphonates (Bisphosphonates)IBA 06/2022
1	Tamoxifen FDA LinkGeneric 06/2022
1	Denosumab FDA Link 06/2022
1	CalciumIBA 06/2022
1	Letrozole (Femara)FDA LinkGeneric 06/2022
1	Cholecalciferol (Vitamin D3)FDA Link 06/2022
1	Aromatase InhibitorsIBA 06/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	Indicators and Reagents (Reagents)IBA 11/2019
1	Long-Acting Thyroid Stimulator (LATS)IBA 11/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2019
1	Bevacizumab (Avastin)FDA Link 10/2019
1	Immune Checkpoint InhibitorsIBA 10/2019
1	NivolumabIBA 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019
1	Diethylcarbamazine (Hetrazan)FDA Link 01/2017
1	Ivermectin (Mectizan)FDA Link 01/2017
1	AntigensIBA 12/2016
1	Vitamin K FDA Link 10/2008
1	AnticoagulantsIBA 10/2008

3	Drug Therapy (Chemotherapy) 03/2024 - 10/2019
3	Therapeutics 11/2022 - 10/2019
1	Morcellation 01/2023
1	Secondary Prevention 06/2022
1	Curettage 01/2021
1	Hysterectomy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Radiotherapy 01/2021
1	Immunotherapy 10/2019
1	Mass Drug Administration 01/2017